FDA-ready in 12 months by turning complexity into speed. Read the Case Study.
FDA-ready in 12 months by turning complexity into speed. Read the Case Study.
Biomanufacturing World Summit
November 10 - November 12
Join us at Booth #31
Hilton San Diego Bayfront, San Diego, CA
If you are attending Biomanufacturing World Summit in San Diego this November, we would love to connect with you!
Avid Bioservices brings decades of experience in biologics development and manufacturing, supporting innovators from early-stage development through commercial production. Whether you’re scaling up a complex biologic of redefining your process, our team is ready to explore how our tailored CDMO solutions can support your goals.
Join Our Lunch Round Table Discussion
Tuesday, November 11 | 12:45 PM – 1:45 PM
Themed Lunch Discussion at BMWS 2025
Rich Richieri, Chief Operations Officer (COO) at Avid Bioservices, will lead a focused round table discussion on: “Mid-Phase Tech Transfer: Onshoring Strategies, Operational Pitfalls, and Lessons Learned“.
This intimate session is limited to 10 participants and offers a unique opportunity to engage directly with Rich and peers on the challenges and solutions surrounding mid-phase tech transfer and onshoring strategies.
Why Meet with Avid Bioservices?
Meet Our Experts
Our team will be onsite to discuss:
Don’t miss this opportunity to connect with Avid Bioservices at Booth #31 and bring your vision to life!
Related Events
Tustin, CA, USA – September 15, 2025 – Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth Bilenberg as its new […]
Read moreSOUTH SAN FRANCISCO, California – August 05, 2025 – Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical […]
Read moreDownload PDF Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO […]
Read moreDownload PDFAvid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger TUSTIN, Calif., February 5, 2025 — Avid […]
Read moreDownload PDFTUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve […]
Read moreDownload PDFTUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing […]
Read more